SCHEMBL6176663

SCHEMBL6176663

CC(c1ccncc1NC(N)=O)C1NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.39
CXCR3 P49682 1/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 2/20 0.34
GSK3A P49840 2/20 0.34
GSK3B P49841 2/20 0.34
GPR139 Q6DWJ6 1/20 0.34
FLT1 P17948 2/20 0.33
KDR P35968 2/20 0.33
P2RY1 P47900 2/20 0.33
P2RY2 P41231 1/20 0.33
P2RY14 Q15391 1/20 0.33
ABL1 P00519 1/20 0.33
TRPV1 Q8NER1 1/20 0.33
NTRK1 P04629 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6171763 0.92 LMNA (0.38) LMNACXCR3NPC1RAB9AL3MBTL1
SCHEMBL6174779 0.90 LMNA (0.36) LMNACXCR3NPC1RAB9AL3MBTL1
SCHEMBL6175831 0.89 NPC1 (0.46) LMNANPC1RAB9AKDRP2RY1
SCHEMBL6173186 0.88 LMNA (0.40) LMNACXCR3NPC1RAB9AL3MBTL1
SCHEMBL6277100 0.88 GSK3A (0.38) NPC1RAB9AMAPTGSK3AGSK3B
SCHEMBL6174987 0.88 GAA (0.41) LMNANPC1RAB9APOLBMAPT
SCHEMBL6172197 0.87 LMNA (0.40) LMNACXCR3NPC1RAB9AL3MBTL1
SCHEMBL6177285 0.87 TDP1 (0.42) LMNAMAPTGSK3AGSK3B
SCHEMBL6175651 0.87 GSK3B (0.41) LMNAL3MBTL1MAPTGSK3AGSK3B
SCHEMBL6176359 0.86 LMNA (0.39) LMNACXCR3NPC1RAB9AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed